Related Experiment Video
Updated: Sep 14, 2026
The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
Published on: June 16, 2018
Cellular basis for the inefficacy of 5-FU in human colon carcinoma
Abstract:
Five established human colorectal carcinoma cell lines with distinct phenotypic properties were exposed to different concentrations of 5-FU for varying time intervals. Effects were measured by sequential cell counts and by inhibition of colony formation. Treatment for 1 hr with 1 microgram/ml barely decreased survival of all cell lines as measured by colony formation; at a concentration of 100 microgram/ml, survival was modestly reduced for all cell lines, and for concentrations of 1000 microgram/ml, survival was decreased by greater than 50%. Extending the length of the treatment interval markedly increased the degree of cell kill for all concentrations of 5-FU. Treatment for greater than 24 hrs resulted in almost complete extermination of colony-forming cells, even for relatively resistant cell lines. The effect of 5-FU treatment on cell number was more complex and depended on drug concentration, length of treatment, and type of cell line. In general, decrements in cell numbers were somewhat related to both drug concentration and length of treatment interval, especially if performed 7 days after terminating drug treatment. Earlier cell counts were inconclusive and the same result could be obtained for different drug concentrations or treatment intervals. Furthermore, these results would change on a daily basis. More important, cell count results never correlated with the survival endpoint measured by inhibition of colony formation. Our results suggest that enhancement of the currently poor performance of 5-FU in the treatment of human colon carcinoma could originate from changing the administration modality to long-term infusion.
Insights
Long-term 5-fluorouracil (5-FU) infusion significantly improves colorectal cancer cell kill. This study suggests modifying 5-FU administration enhances its effectiveness against colon carcinoma.
Area of Science:
- Oncology
- Pharmacology
- Cell Biology
Background:
- 5-fluorouracil (5-FU) is a key chemotherapy agent for colorectal carcinoma.
- Current 5-FU treatment modalities show limited efficacy.
- Understanding 5-FU's dose-response and time-dependent effects is crucial for optimizing treatment.
Purpose of the Study:
- To evaluate the impact of varying 5-FU concentrations and treatment durations on colorectal carcinoma cell survival.
- To compare the reliability of cell count versus colony formation assays in measuring 5-FU efficacy.
- To explore potential improvements in 5-FU administration for enhanced colorectal cancer treatment.
Main Methods:
- Exposure of five human colorectal carcinoma cell lines to diverse 5-FU concentrations and time intervals.
- Assessment of cell survival using sequential cell counts and colony formation inhibition assays.
- Analysis of the correlation between drug exposure parameters and cell viability endpoints.
Main Results:
- Short-term 5-FU treatment (1 hour) showed minimal impact on cell survival.
- Increased 5-FU concentrations and prolonged treatment durations ( > 24 hours) significantly enhanced cancer cell kill.
- Cell count measurements were less reliable and did not correlate with survival outcomes compared to colony formation assays.
Conclusions:
- Prolonged 5-FU treatment is more effective in eradicating colorectal cancer cells than short-term administration.
- Long-term infusion of 5-FU may represent a superior administration strategy for improving treatment outcomes.
- Colony formation assay is a more robust method for assessing 5-FU efficacy in colorectal carcinoma models.
